December 16, 2025 02:51 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Centre moves to replace MGNREGA with 'G Ram G', sets stage for winter session showdown | Messi surrounded by VIPs, fans rage: Five held in stadium vandalism case | 'Messi was uncomfortable, lost his cool!': Ex-India footballer reveals what really happened at chaotic Kolkata stadium | PM Modi embarks on historic three-nation visit to Jordan, Ethiopia, and Oman | Caught in Thailand! Fugitive Goa nightclub owners detained after deadly fire kills 25 | After Putin’s blockbuster Delhi visit, Modi set to host German Chancellor Friedrich Merz in January | Delhi High Court slams govt, orders swift compensation as IndiGo crisis triggers fare shock and nationwide chaos | Amazon drops a massive $35 billion India bet! AI push, 1 million jobs and big plans revealed at Smbhav Summit | IndiGo’s ‘All OK’ claim falls apart! Govt slaps 10% flight cut after weeklong chaos | Centre finally aligns IndiGo flights with airline's operating ability, cuts its winter schedule by 5%
Covid-19 Vaccine
Image Credit: Firhad Hakim Twitter

Kolkata: Firhad Hakim gets vaccinated in Covaxin's phase 3 trial

| @indiablooms | Dec 02, 2020, at 11:42 pm

Kolkata/IBNS: Kolkata Municipal Corporation (KMC)'s chairman of board of administrators and West Bengal Minister, Firhad Hakim, on Wednesday got vaccinated in the third phase of trial of India's indigenous vaccine candidate against Covid-19, Covaxin.

The third phase trial was inaugurated in the city by West Bengal Governor Jagdeep Dhankhar at Kolkata's National Institute of Cholera and Enteric Disease (NICED)  on Tuesday.

After getting vaccinated, Hakim, who became the second candidate to take the dose of Covaxin in the trial, said, "I am fully fine after getting vaccinated."

"I don't care even if I die. My vaccination will be fruitful when the entire country will get vaccinated," he said.

A total of 1,000 people will participate in the third phase of the vaccine trial of Covaxin developed by Indian biotechnology company Bharat Biotech.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.